The expression of T cell related costimulatory molecules in multiple myeloma

Leukemia and Lymphoma

Volumn 31, Issue 3-4, 1998, Pages 379-384

  Brown, R D ^a   Pope, B ^a   Yuen, E ^a   Gibson, J ^a   De Joshua, ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

B7 1; CD28; Costimulatory molecules; Multiple myeloma; T cell

Indexed keywords

CD38 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CLINICAL ARTICLE; CLONAL ANERGY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0032427590     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809059231     Document Type: Article

References (18)

1. Moss, P., Gillespie, G., Frodsheim, P., Bell, J. and Reyburn, H. (1996) Clonal populations of CD4+ and CD8+ T cells in patients with multiple myeloma and paraproteinemia. Blood, 87, 3297-3306.
2. Kay, N.B., Oken, M.M., Kyle, R., Van Ness, B., Kalish, L., Leong, T. and Griepp, P. (1995) Sequential phenotyping of myeloma patients on chemotherapy : persistence of activated T cells and natural killer cells. Leuk Lymphoma, 16, 351-354.
3. Massai, M., Bianchi, A., Attsiano, C, Peola, S, Redoglia, V., Diazani, U. and Pileri, A. (1992) Rapid generation of antiplasma cell activity in the bone marrow of patients with CD3-activated T cells. Blood, 82, 1787-1797.
4. Mills, K.H. and Cawley, J.C. (1983) Abnormal monoclonal antibody-defined helper/suppressor T-cell subpopulations in multiple myeloma: relationship to treatment and clinical stage. Br J Haematol, 53, 271-275.
5. Serra, H.M., Mant, M.J., Ruether, B.A., Ledbetter, J.A. and Pilarski, L.M. (1988) Selective loss of CD4+ CD45R T cells in peripheral blood of multiple myeloma patients. J Clin Immunol, 8, 259-265.
6. San Miguel, J.F., Gonzalez, M., Gascon, A., Moro, M.J., Hernandez, J.M., Ortega, F., Jimenez, R., Guerras, L., Romero, M. and Cassanova, F. (1992) Lymphoid subsets and prognostic factors in multiple myeloma. Br J Haematol, 80, 305-309.
7. Brown, R.D., Yuen, E., Nelson, M., Gibson, J. and Joshua, D.E. (1996) The prognostic significance of T cell receptor β gene rearrangements and idiotype-reactive T cells in multiple myeloma. Leukemia, 11, 1312-1317.
8. Schultze, J., Nadler, L.M. and Gribben, J.G. (1996) B7-mediated costimulation and the immune response. Blood Rev, 10, 111-127.
9. Hellstrom, K.E., Hellstrom, I. and Chen, L. (1995) Can costimulated tumor immunity be therapeutically efficacious? Immunol Rev, 145, 123-145.
10. Allison, J.P., Hurwitz, A.A. and Leach, D.R. (1995) Manipulation of costimulatory signals to enhance antitumor T-cell responses. Curr Opinion Immunol, 7, 682-686.
11. Freedman, G.J., Freedman, A.S., Horowitz, J.C., Daley, J. and Nadler, L.M. (1987) B7, a B-cell restricted antigen that identifies preactivated B cells. J Immunol, 139, 3260-3267.
12. Kornbluth, J. (1995) Potential role of CD28-B7 interactions in the growth of of myeloma plasma cells. Curr Topics Microbiol Immunol, 194, 43-49.
13. Joshua, D.E., Penny, R., Mathews, J.P., Laidlaw, C.R., Gibson, J., Bradstock, K., Wolf, M. and Goldstein, D. (1997) Australian Leukaemia Study Group Myeloma II: a randomized trial of intensive combination chemotherapy with or without interferon in patients with myeloma. Br J Haematol, 97, 38-45.
14. Hata, H., Xiao, H., Petrucci, M.T., Woodliff, J., Chang, R. and Epstein, J. (1993) Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells. Blood, 81, 3357-3364.
15. Joshua, D.E., Petersen, A., Brown, R., Pope, B., Snowdon, L. and Gibson, J. (1996) The labelling index of primitive plasma cells determines the clinical behaviour of patients with myelomatosis. Br J Haematol, 94, 76-81.
16. Linsley, P.S., Bradshaw, J., Urnes, M., Grosmaire, L. and Ledbetter, J.A. (1993) CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling. J Immunol, 150, 3161-3169.
17. Dunussi-Joannopolous, K., Weinstein, H.J., Nickerson, P.W., Strom, T.B., Burakoff, S.J., Croop, J.M. and Arceci, R.J. (1996) Irradiated B7-1 transduced promary acute myelogenous leukaemia (AML) cells can be used as therapeutic vaccined in murine AML. Blood, 87, 2938-2946.
18. Matulonis, U., Dosiou, C., Freeman, G., Lamont, C., Mauch, P., Nadler, L.M. and Griffin, J.D. (1996) B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell mediated antileukaemia immunity. J Immunol 156, 1126-1131.